{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:31:01Z","timestamp":1760369461928,"version":"3.37.3"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001962","name":"World Anti-Doping Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.toxlet.2018.04.026","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T22:35:13Z","timestamp":1524609313000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Androgen- and estrogen-receptor mediated activities of 4-hydroxytestosterone, 4-hydroxyandrostenedione and their human metabolites in yeast based assays"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2157-4711","authenticated-orcid":false,"given":"Annekathrin Martina","family":"Keiler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Zierau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvi","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Diel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm","family":"Sch\u00e4nzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Machalz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Wolber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7407-8300","authenticated-orcid":false,"given":"Maria Kristina","family":"Parr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2018.04.026_bib0005","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00204-012-0905-4","article-title":"Characterization of identity, metabolism and androgenic activity of 17-hydroxyandrosta-3,5-diene by GC\u2013MS and a yeast transactivation system","volume":"86","author":"Bauer","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0010","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/endo-100-6-1684","article-title":"The effect of an aromatase inhibitor, 4-hydroxy-4-androstene- 3,17-dione, on estrogen-dependent processes in reproduction and breast cancer1","volume":"100","author":"Brodie","year":"1977","journal-title":"Endocrinology"},{"key":"10.1016\/j.toxlet.2018.04.026_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/14756369209040745","article-title":"Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptor","volume":"6","author":"Davies","year":"1992","journal-title":"J. Enzym. Inhib."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.toxlet.2006.12.004","article-title":"Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping","volume":"169","author":"Diel","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1677\/JME-07-0175","article-title":"C2C12 myoblastoma cell differentiation and proliferation is stimulated by androgens and associated with a modulation of myostatin and Pax7 expression","volume":"40","author":"Diel","year":"2008","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0959-8049(05)80065-6","article-title":"An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients","volume":"28","author":"Dowsett","year":"1992","journal-title":"Eur. J. Cancer (Oxf. Engl. 1990)"},{"issue":"Suppl. 7","key":"10.1016\/j.toxlet.2018.04.026_bib0035","first-page":"S3","article-title":"Aromatase inhibition: basic concepts, and the pharmacodynamics of formestane","volume":"5","author":"Dowsett","year":"1994","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<587::AID-JCC4>3.0.CO;2-Q","article-title":"Merck molecular force field. IV. conformational energies and geometries for MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1258\/000456303766476977","article-title":"Anabolic steroids in sport: biochemical, clinical and analytical perspectives","volume":"40","author":"Kicman","year":"2003","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.steroids.2006.11.018","article-title":"Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: mass spectrometric identification of urinary metabolites","volume":"72","author":"Kohler","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.toxlet.2018.04.026_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2009.08.005","article-title":"Prenylation has a compound specific effect on the estrogenicity of naringenin and genistein","volume":"118","author":"Kretzschmar","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0960-0760(01)00029-2","article-title":"Pharmacokinetics and metabolism of formestane in breast cancer patients","volume":"77","author":"L\u00f8nning","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0070","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jsbmb.2009.12.008","article-title":"Detection of the misuse of steroids in doping control","volume":"121","author":"Parr","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0075","series-title":"Recent Advances in Doping Analysis, (Sport und Buch Strau\u00df, K\u00f6ln)","first-page":"129","article-title":"Analytical properties of 4-hydroxysteroids and some esters","author":"Parr","year":"2004"},{"key":"10.1016\/j.toxlet.2018.04.026_bib0080","series-title":"Recent Advances in Doping Analysis, (Sport und Buch Strau\u00df, K\u00f6ln)","first-page":"65","article-title":"Synthesis of reference compounds for the identification of metabolites of 4-hydroxytestosterone","author":"Parr","year":"2005"},{"key":"10.1016\/j.toxlet.2018.04.026_bib0085","doi-asserted-by":"crossref","first-page":"9696","DOI":"10.1021\/ja202946k","article-title":"Design and structure of stapled peptides binding to estrogen receptors","volume":"133","author":"Phillips","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0378-4347(91)80372-J","article-title":"Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography-mass spectrometry","volume":"565","author":"Poon","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-4347(92)80197-X","article-title":"Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography-mass spectrometry","volume":"576","author":"Poon","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1677\/joe.0.1580327","article-title":"Several environmental oestrogens are also anti-androgens","volume":"158","author":"Sohoni","year":"1998","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0105","article-title":"CR1447 in endocrine responsive-HER2neg and TN-ARpos breast cancer","author":"Vetter","year":"2017","journal-title":"Clin. Natl. Libr. Med."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2165\/00002512-199609040-00006","article-title":"Formestane: a review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer","volume":"9","author":"Wiseman","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1016\/j.toxlet.2018.04.026_bib0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0120","series-title":"The Practice of Medicinal Chemistry","first-page":"489","article-title":"Chapter 21 \u2013 pharmacophore identification and pseudo-Receptor modeling","author":"Wolber","year":"2015"},{"key":"10.1016\/j.toxlet.2018.04.026_bib0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00204-010-0590-0","article-title":"Long-term detection of methyltestosterone (ab-) use by a yeast transactivation system","volume":"85","author":"Wolf","year":"2011","journal-title":"Arch. Toxicol."},{"year":"2018","series-title":"The 2018 Prohibited List","author":"World Anti-Doping Agency","key":"10.1016\/j.toxlet.2018.04.026_bib0130"},{"key":"10.1016\/j.toxlet.2018.04.026_bib0135","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1074\/jbc.M109.085779","article-title":"Identification of SRC3\/AIB1 as a preferred coactivator for hormone-activated androgen receptor","volume":"285","author":"Zhou","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2018.04.026_bib0140","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.steroids.2008.04.015","article-title":"Detection of anabolic steroid abuse using a yeast transactivation system","volume":"73","author":"Zierau","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.toxlet.2018.04.026_bib0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1530\/EC-17-0174","article-title":"Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients","volume":"6","author":"Zweifel","year":"2017","journal-title":"Endocr. Connect"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418301644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418301644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T20:39:59Z","timestamp":1565296799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427418301644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"alternative-id":["S0378427418301644"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.04.026","relation":{},"ISSN":["0378-4274"],"issn-type":[{"type":"print","value":"0378-4274"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen- and estrogen-receptor mediated activities of 4-hydroxytestosterone, 4-hydroxyandrostenedione and their human metabolites in yeast based assays","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}